| Sugammadex use in patients with end-stage renal disease: a historical cohort study P Stephania, SB Porter, IE Porter II, RJ Ross Canadian Journal of Anesthesia 67 (12), 1789-1797, 2020 | 30 | 2020 |
| Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation LTJ Hickson, AD Rule, B Thorsteinsdottir, RC Shields, IE Porter, ... Journal of vascular surgery 68 (5), 1505-1516, 2018 | 28 | 2018 |
| Career interest and perceptions of nephrology: a repeated cross-sectional survey of internal medicine residents MN Daniels, S Maynard, I Porter, H Kincaid, D Jain, N Aslam PLoS one 12 (2), e0172167, 2017 | 28 | 2017 |
| Propranolol in angina pectoris. Comparison of long-acting and standard-formulation propranolol. JO Parker, A Porter, JD Parker Circulation 65 (7), 1351-1355, 1982 | 25 | 1982 |
| Inpatient warfarin management: pharmacist management using a detailed dosing protocol NL Dawson, IE Porter, D Klipa, WR Bamlet, MA Hedges, MJ Maniaci, ... Journal of thrombosis and thrombolysis 33, 178-184, 2012 | 22 | 2012 |
| Collapsing glomerulopathy in systemic lupus erythematosus K Abadeer, AA Alsaad, XJ Geiger, IE Porter Case Reports 2017, bcr2016217840, 2017 | 10 | 2017 |
| Rare allergic reaction of the kidney: sitagliptin-induced acute tubulointerstitial nephritis AA Alsaad, SM Dhannoon, SAL Pantin, IE Porter Case Reports 2016, bcr2016216297, 2016 | 8 | 2016 |
| Behçet’s syndrome and focal segmental glomerulosclerosis with nephrotic syndrome–successful treatment with etanercept D Leonard, C Cortese, HM Wadei, IE Porter II, N Aslam Clinical Nephrology 89 (5), 371, 2018 | 6 | 2018 |
| CORONARY VASOCONSTRICTOR EFFECTS OF NOREPINEPHRINE IN PATIENTS WITH CORONARY ATHEROSCLEROSIS-EVIDENCE FROM SELECTIVE MEASUREMENT OF CORONARY FLOW VELOCITY CW White, S Chierchia, RF Wilson, A Porter, A Maseri JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 5 (2), 432-432, 1985 | 6 | 1985 |
| Advanced practice provider care team models: Best practices from an academic medical center A Chaney, G Beliles, A Keimig, I Porter The Journal of Ambulatory Care Management 45 (2), 126-134, 2022 | 5 | 2022 |
| Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case–Control Study IE Porter II, WC Palmer, AS Parker, DO Hodge, NN Diehl, WE Haley Journal of clinical and experimental hepatology 8 (4), 375-379, 2018 | 5 | 2018 |
| Minimal change disease and subacute interstitial nephritis in association with Edwardsiella tarda gastroenteritis following oyster consumption A Bui, C Cortese, CR Libertin, IE Porter II IDCases 25, e01236, 2021 | 3 | 2021 |
| Racial and ethnic disparities in cardiovascular disease risk among patients with chronic kidney disease DA Adedinsewo, IE Porter, RO White, LTJ Hickson Current Cardiovascular Risk Reports 16 (11), 145-157, 2022 | 2 | 2022 |
| Kidney Outcomes Following Utilization of Molecular Adsorbent Recirculating System CL Trautman, M Khan, LW Baker, N Aslam, P Fitzpatrick, I Porter II, M Mao, ... Kidney International Reports 8 (10), 2100-2106, 2023 | 1 | 2023 |
| Secondary oxalate nephropathy in an athletic woman with a duplex collecting system and ureteral fibrosis A Bui, C Cortese, IE Porter BMJ case reports 14 (12), 2021 | 1 | 2021 |
| Association of Ancillary Pathology Findings in Non-neoplastic Renal Parenchyma and Renal Outcomes of Robotic-Assisted Partial Nephrectomy LE Geldmaker, AE Kahn, KA Parikh, IE Porter, DA Haehn, EM Bajalia, ... Frontiers in Surgery 8, 652524, 2021 | 1 | 2021 |
| In reply: Sugammadex in end-stage renal disease: Too early for a “free-pass” JR Renew, SB Porter, I Porter, S Paredes Canadian Journal of Anesthesia/Journal canadien d'anesthésie 68, 266-267, 2021 | 1 | 2021 |
| BONE MARROW-DERIVED MESENCHYMAL STEM CELL THERAPY IN CHRONIC KIDNEY DISEASE: AN EARLY PHASE CLINICAL TRIAL K Elhusseiny, L Alatta, ZK Snow, C Skaff, M Yin, N Aslam, I Porter, M Mao, ... Cytotherapy 26 (6), S48, 2024 | | 2024 |
| Corticosteroid-induced hyperammonaemic encephalopathy in a woman with late-onset ornithine transcarbamylase deficiency BJ McCormick, LV Ritchie, IE Porter BMJ Case Reports CP 17 (5), e255793, 2024 | | 2024 |
| Mesenchymal Stem/Stromal Cells: MESENCHYMAL STEM CELL THERAPY IN DIABETIC KIDNEY DISEASE: EVALUATING SAFETY AND RESPONSE PREDICTORS K Elhusseiny, L Alatta, ZK Snow, C Skaff, N Aslam, I Porter, M Mao, ... Cytotherapy 25 (6), S61-S62, 2023 | | 2023 |
